The results revealed that sensitivity, specificity, and AUC of the combination of Asprosin and Nrg-4 for diagnosing T2DM-CHD were 64.9%, 81.2%, and 0.796; such a combination demonstrated significantly improved diagnostic efficacy (Fig. 2). The gene discussed is NRG4; the disease is coronary artery disorder.